Successful response to rituximab in a patient with pure red cell aplasia complicating chronic lymphocytic leukaemia [2]

British Journal of Haematology

Volumn 118, Issue 4, 2002, Pages 1192-

  Batlle, Montserrat ^a   Ribera, Josep Maria ^a   Oriol, Albert ^a   Plensa, Esther ^a   Millá, Fuensanta ^a   Feliu, Evarist ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

CLL; Immune mediated haematological disorders; PCRA; Rituximab

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; PREDNISOLONE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CANCER STAGING; CASE REPORT; CHILL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG RESPONSE; ERYTHROCYTE CONCENTRATE; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN TISSUE; LETTER; LYMPHOCYTIC INFILTRATION; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RETICULOCYTE COUNT; SEROLOGY; TREATMENT FAILURE;

EID: 0036053187     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.36892.x     Document Type: Letter

References (6)

1. Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab)
2. Rituximab: A very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma
3. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease
4. Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia
5. Rituximab in a case of cold agglutinin disease
6. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and anemia